PANCREATIC NEUROENDOCRINE TUMOR G2

Clinical trials for PANCREATIC NEUROENDOCRINE TUMOR G2 explained in plain language.

Never miss a new study

Get alerted when new PANCREATIC NEUROENDOCRINE TUMOR G2 trials appear

Sign up with your email to follow new studies for PANCREATIC NEUROENDOCRINE TUMOR G2, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Two-Pronged attack on rare digestive cancers

Disease control Recruiting now

This study is testing if a two-step treatment works better for patients with a specific type of digestive system cancer that has spread to the liver. First, surgeons remove as much of the tumor as possible. Then, within 90 days, patients receive a targeted radiation drug that see…

Matched conditions: PANCREATIC NEUROENDOCRINE TUMOR G2

Phase: PHASE4 • Sponsor: Vanderbilt-Ingram Cancer Center • Aim: Disease control

Last updated Mar 23, 2026 15:14 UTC

PANCREATIC NEUROENDOCRINE TUMOR G2

Get alerted when new PANCREATIC NEUROENDOCRINE TUMOR G2 trials appear

Two-Pronged attack on rare digestive cancers